Collyer Law has been named as a finalist in the ALB PAN ASIAN REGULATORY AWARDS 2025 in the category "Regulatory Law Firm of the Year -...

Collyer Law has been named as a finalist at the Asia Legal Awards 2025 in the category " Boutique Law Firm of the Year". The awards, now...

Collyer Law advised a Singapore-based health and longevity clinic focused on reversing biological aging, on its SAFE investment round from an international venture capital fund. The funding will support clinical research, product development and market expansion.

Collyer Law LLC advised a venture capital fund on its investment in the Series A fundraising round of a synthetic biotechnology start-up that develops livestock disease prevention biotechnology. The start-up offers recombinant custom peptides cultivated using synbio microorganisms as an antibiotic replacement for disease prevention and growth promotion in livestock, providing breeders and farmers with humane, sustainable, highly productive agriculture without the use of antib

Collyer Law is advising InfraRiskSG Pte. Ltd. (dba, InfraRisk), a Singapore-based FinTech company with operations in Australia and the...